Home > Healthcare > Medical Devices > Diagnostic Devices > Infectious Disease Diagnostics Market

Infectious Disease Diagnostics Market Size

  • Report ID: GMI5597
  • Published Date: May 2023
  • Report Format: PDF

Infectious Disease Diagnostics Market Size

Infectious Disease Diagnostics Market size was USD 24 billion in 2022 and will exhibit more than 5.5% CAGR from 2023-2032. Rising popularity of point-of-care diagnostic testing techniques to supplement industry growth.

 

The increasing preference for point-of-care diagnostic testing will influence the industry expansion. Rapid results obtained from point-of-care testing are increasingly crucial for prompt diagnosis and treatment in urgent care centres, emergency rooms, and ambulances. The growing need for rapid diagnosis and treatment helps to enhance patient outcomes while catering to several illnesses or infectious diseases has made way for innovations, further driving the market share.

Limited awareness pertaining to infection control and prevention as well as personal health and hygiene, specifically in the underdeveloped nations may pose as a major barrier for the demand for infectious disease diagnostics. Numerous hospitals are facing the challenges of inadequate infrastructure, such as poor water sanitation, and hygiene facilities. Lack of training among healthcare professionals for infection control in healthcare settings, staff shortages, and ineffective compliance of hospital and patient staff with hygiene standards are other factors limiting the market size

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for Infectious disease diagnostics was USD 24 billion in 2022 and will exhibit more than 5.5% CAGR from 2023-2032 due to the increasing preference for point-of-care diagnostic testing.

Respiratory disease applications will record 6% CAGR from 2023-2032 owing to the significant rise in the number of pathogens that cause respiratory infections include bacteria, viruses, fungi, and parasites.

North America infectious disease diagnostics market is estimated to exceed USD 17 billion by 2032 due to the surging frequency of infectious diseases and the scaling deployment of cutting-edge diagnostic technologies.

Abbott Laboratories, BioMerieus SA, Becton Dickinson and Company, Danaher Corporation, Bio-Rad Laboratories, F Hoffman-La Roche, Hologic Inc., Qiagen Inc., Siemens Healthineers, and Thermo Fisher Scientific Inc. are some infectious disease diagnostic companies. ?

Infectious Disease Diagnostics Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 366
  • Countries covered: 29
  • Pages: 380
 Download Free Sample